Volume 22, Number 8—August 2016
Research
Virulence and Evolution of West Nile Virus, Australia, 1960–2012
Table 2
Strain | Year of isolation | Monoclonal antibodies, by specificity |
|||||||
---|---|---|---|---|---|---|---|---|---|
Panflavivirus, 4G2, anti-env | Pan-WNV, 2B2, anti-env | WNVKUN-specific |
Glycosylated E, 17D7 | Unglycosylated E, 3.101C | MVEV-specific, 10C6 | ||||
10A1, anti-env | 5D4, anti-NS5 | 5H1, anti-NS5 | |||||||
WNVKUN† | |||||||||
KUN1960 | 1960 | + | + | + | + | + | – | + | – |
Boort | 1984 | + | + | + | + | + | + | – | – |
K2499 | 1984 | + | + | + | + | + | + | – | – |
SH183 | 1991 | + | + | + | + | + | + | – | – |
K6453 | 1991 | + | + | + | + | + | + | – | – |
Hu6774 | 1991 | + | + | + | + | + | + | – | – |
Gu0631 | 2000 | + | + | + | + | + | + | – | – |
Gu1009 | 2000 | + | + | + | + | + | + | – | – |
K68967 | 2009 | + | + | + | + | – | + | – | – |
P9974 | 2009 | + | + | + | + | – | + | – | – |
NSW2011 | 2011 | + | + | + | + | – | + | – | – |
K74015 | 2011 | + | + | + | + | – | + | – | – |
NSW2012 |
2012 |
+ |
+ |
+ |
+ |
– |
+ |
– |
– |
Reference | |||||||||
WNVNY99 | 1999 | + | + | – | + | – | + | – | – |
MVEV1–51 | 1951 | + | – | – | – | – | – | – | + |
*Binding of a monoclonal antibody was designated as positive if the optical density was at least double the optical density of the negative control (mock-infected C6/36 cells). E, envelope protein; MVEV, Murray Valley encephalitis virus; NS5, nonstructural protein 5; WNV, West Nile virus; WNVKUN, Kunjin strain of WNV; +, positive; –, negative.
†WNVKUN strains collected during 1960–2012, Australia.
1Current affiliation: QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
2These authors contributed equally to the major technical aspects of the work.
3Current affiliation: Willamette University, Salem, Oregon, USA.
4These authors served as joint senior authors.
Page created: July 15, 2016
Page updated: July 15, 2016
Page reviewed: July 15, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.